The Weight Loss Paradox Losing weight should make people happier, right
It is not a drug, food, or cosmetic, and may not be misbranded, misused, or mislabeled as such
The address can be found, but it is not prominently listed on the website
As of February 23, 2026, the manufacturer has a promotion for the Zepbound Self Pay Journey Program, which lowers rates to $449 for each 1-month supply of the 7.5 mg, 10 mg, 12.5 mg, and 15 mg Zepbound single-dose vial or Zepbound KwikPen for single-patient-use
However, at the GLP-1 receptor, tirzepatide shows bias towards cAMP (a messenger associated with regulation of glycogen, sugar and lipid metabolism) generation, rather than -arrestin recruitment
Glucagon-like peptide 1 (GLP-1) receptor agonists, commonly referred to as GLP-1 drugs, are widely recognized for their use in managing type 2 diabetes and supporting weight loss